THE MERCK VETERINARY MANUAL
Print Topic

Sections

Chapters

Oesophagostomum spp in Pigs

-
-

Oesophagostomum spp are prevalent worldwide; O dentatum is the most common species, while O quadrispinulatum appears to be slightly more pathogenic. All Oesophagostomum species are host-specific. The adults are found in the lumen of the large intestine; they are 8–12 mm long, slender, and white or gray. The life cycle is direct. Infection results from ingestion of L3 larvae, which penetrate the mucosa of the large intestine within a few hours after ingestion and return to the lumen in 6–20 days. The prepatent period is 17–35 days. A periparturient rise in worm egg output has been observed in sows from 2 wk before parturition to weaning; however, this phenomenon is far less constant in pigs than sheep and its epidemiologic importance is questionable. Most infections are asymptomatic, but heavily infected pigs may show anorexia, emaciation, and GI disturbances.

The serosa shows small nodules, their size reflecting species and previous exposure. In severe cases, the intestinal wall may be thickened and necrotic. Heavy infections may reduce the lactation capacity of sows and the body weight of growing pigs. Infection induces only moderate immunity; hence, prevalence of nodular worms tends to be higher in the older age groups (sows, boars). In patent infections, typical strongyle eggs (66–80 × 38–47 μm) are found in feces, often in large numbers. These can be differentiated from those of Hyostrongylus by larval culture (Oesophagostomum L3 larvae are shorter, thicker, and move more slowly). At necropsy, the worms and lesions are readily seen. The benzimidazoles, levamisole, piperazines, dichlorvos, pyrantel tartrate, and ivermectin are effective, but anthelmintic resistance has been observed for benzimidazoles, levamisole, and pyrantel. A diet composed of highly degradable carbohydrates may support worm control by creating unfavorable conditions, which decrease worm establishment and fecundity.

Last full review/revision March 2012 by Allan Roepstorff, DSc, PhD, MSc

Copyright     © 2009-2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use    Permissions